Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
24
TDOC Quote, Financials, Valuation and Earnings
Last price:
$7.25
Seasonality move
:
5.17%
Day range:
$7.12 - $7.28
52-week range:
$6.35 - $15.21
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
0.92x
Volume:
1.7M
Avg. volume:
5.1M
1-year change:
-21.71%
Market cap:
$1.3B
Revenue:
$2.6B
EPS (TTM):
-$1.28
Analysts' Opinion
-
Consensus RatingTeladoc Health, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 22 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.18, Teladoc Health, Inc. has an estimated upside of 26.58% from its current price of $7.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $7.25.
Fair Value
-
According to the consensus of 26 analysts, Teladoc Health, Inc. has 26.58% upside to fair value with a price target of $9.18 per share.
TDOC vs. S&P 500
-
Over the past 5 trading days, Teladoc Health, Inc. has underperformed the S&P 500 by -1.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Teladoc Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Teladoc Health, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Teladoc Health, Inc. reported revenues of $626.4M.
Earnings Growth
-
Teladoc Health, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Teladoc Health, Inc. reported earnings per share of -$0.28.
Enterprise value:
1.6B
EV / Invested capital:
0.66x
Price / LTM sales:
0.50x
EV / EBIT:
--
EV / Revenue:
0.63x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
11.78x
Price / Operating cash flow:
9.32x
Enterprise value / EBITDA:
8.42x
Gross Profit (TTM):
$1.4B
Return On Assets:
-6.77%
Net Income Margin (TTM):
-8.84%
Return On Equity:
-15.44%
Return On Invested Capital:
-7.94%
Operating Margin:
-5.66%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.6B | $2.6B | $2.5B | $640.5M | $626.4M | |
| Gross Profit | $1.5B | $1.5B | $1.4B | $371.2M | $350.9M | |
| Operating Income | -$213M | -$196.6M | -$178.6M | -$40.4M | -$35.5M | |
| EBITDA | $36.9M | $196.1M | $190.3M | $51.5M | $56.7M | |
| Diluted EPS | -$24.66 | -$5.78 | -$1.28 | -$0.19 | -$0.28 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.3B | $1.4B | $1.6B | $1.1B | |
| Total Assets | $17.7B | $8.1B | $4.3B | $3.5B | $2.9B | |
| Current Liabilities | $302.1M | $411.4M | $402.6M | $931.4M | $405.1M | |
| Total Liabilities | $1.7B | $2.1B | $2B | $2B | $1.5B | |
| Total Equity | $16B | $6.1B | $2.3B | $1.5B | $1.4B | |
| Total Debt | $1.3B | $1.6B | $1.6B | $1.6B | $1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $285.5M | $337.9M | $288.4M | $110.2M | $95.2M | |
| Cash From Investing | -$173.7M | -$130.9M | -$261.3M | -$31.1M | -$48.7M | |
| Cash From Financing | $17M | $4.5M | -$546.6M | $698K | $517K | |
| Free Cash Flow | $111.8M | $206.9M | $136.1M | $79M | $63.8M | |
TDOC
Sector
Market Cap
$1.3B
$28M
Price % of 52-Week High
47.67%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
7.7%
-1.54%
1-Year Price Total Return
-21.71%
-17.48%
Beta (5-Year)
2.036
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.26
200-day SMA
Sell
Level
$7.70
Bollinger Bands (100)
Sell
Level
7.18 - 8.4
Chaikin Money Flow
Sell
Level
-5.5M
20-day SMA
Sell
Level
$7.45
Relative Strength Index (RSI14)
Sell
Level
43.95
ADX Line
Buy
Level
10.28
Williams %R
Neutral
Level
-78.6638
50-day SMA
Sell
Level
$7.75
MACD (12, 26)
Buy
Level
1.90
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-383.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.902)
Sell
CA Score
(Annual)
Level (-0.675)
Buy
Beneish M-Score
(Annual)
Level (-4.2421)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.1771)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, TDOC has received 4 Buy ratings 22 Hold ratings, and 0 Sell ratings. The TDOC average analyst price target in the past 3 months is $9.18.
-
Where Will Teladoc Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Teladoc Health, Inc. share price will rise to $9.18 per share over the next 12 months.
-
What Do Analysts Say About Teladoc Health, Inc.?
Analysts are divided on their view about Teladoc Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Teladoc Health, Inc. is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is Teladoc Health, Inc.'s Price Target?
The price target for Teladoc Health, Inc. over the next 1-year time period is forecast to be $9.18 according to 26 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 22 analysts rate the stock a Hold.
-
Is TDOC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Teladoc Health, Inc. is a Hold. 22 of 26 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TDOC?
You can purchase shares of Teladoc Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Teladoc Health, Inc. shares.
-
What Is The Teladoc Health, Inc. Share Price Today?
Teladoc Health, Inc. was last trading at $7.25 per share. This represents the most recent stock quote for Teladoc Health, Inc.. Yesterday, Teladoc Health, Inc. closed at $7.25 per share.
-
How To Buy Teladoc Health, Inc. Stock Online?
In order to purchase Teladoc Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get TDOC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TDOC
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
0.92x
1.82x
Price / LTM sales
0.50x
1.60x
Growth Metrics
TDOC
Sector
Revenue growth
-2.2%
4.62%
Earnings growth
-44.23%
10.88%
Revenue (5-year growth)
35.95%
6.5%
Earnings forecast
-$0.31
-$0.21
Profitability
TDOC
Sector
Profitability FY 2024
$1.4B
$3.5M
Return on invested capital
-7.94%
-31.77%
Return on assets
-6.77%
-27.96%
Return on equity
-15.44%
-37.63%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Jan
28
Balance Sheet
TDOC
Sector
Total cash
$726.2M
$26.3M
Short term investments
--
$25.7M
Total assets
$3.8B
$78M
Long term debt
$1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
